i22k Ventures provides equity investment, strategic guidance and management expertise to early stage technology companies operating in the biotechnology, healthcare, communications and sustainability sectors.
We invest in early stage, pre-profit companies that have the potential to achieve cash-generative profitability within a 5 year period and work alongside committed and energetic management teams that can demonstrate the following:
- Concise communication of the vision, strategic goals and measures of success.
- Developed technology platforms with clear unique selling points and barriers to entry.
- Understanding of the market drivers and competitive landscape.
- Knowledge and experience in the route-to-market.
- Detailed commercialisation plans and financial models.
For further information please send a one page, non-confidential executive summary of your business plan to .